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Background: The measurement of health-related quality of life (HRQoL) is increasingly recognized as an important
endpoint, as a reflection of the effects of the disease from a patient perspective. Our aim was to evaluate the
factors determining the HRQoL in patients with asthma, according to the EQ-5D questionnaire.
Methods: Patients were included using multi-stage sampling, from Primary Care clinics from all the Autonomous
Communities in Spain. The patients included were: over 18 years-old, with a confirmed diagnosis of asthma for at
least one year, and had visited a Health Centre in the previous 2 years. The characteristics of the asthma disease,
the adherence to treatment, the socio-demographic variables, the smoking habits, and the asthma control were
collected using a questionnaire. The influence of the different variables included in the study on the EQ-5D was
evaluated using multivariate logistic regression analysis.
Results: A total of 2,125 patients were finally included (57.7% females, mean age 48 years). The response rate was
95.4%. Some factors showed a considerable detrimental effect on the HRQoL of asthmatics. Advanced age, lower
educational level and poor control of asthma are significantly associated with a worse quality of life in all the
dimensions assessed by the EQ-5D scale. The baseline severity of the asthma, and having been admitted to hospital
are related to a worse quality of life in 5 of the 6 dimensions analyzed.
Conclusion: In our study, we could identify some factors related to quality of life in asthma patients. The most
important were advanced age, lower education level, and poor control of the asthma.
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The measurement of health-related quality of life
(HRQoL) is increasingly recognized as an important
endpoint, a reflection of the effects of the disease from a
patient’s perspective. It covers a multidimensional con-
cept, not only associated with the disease itself and the
medical actions developed for its management, but also
with the physical, social and psychological functioning of
the patient [1-5]. Although clinical and physiological
parameters are needed to evaluate the disease, these are
not sufficient to understand and assess how the patients
perceive their state of health [6,7].* Correspondence: francisco.javier.gonzalez.barcala@sergas.es
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distribution, and reproduction in any mediumIt is known that asthma negatively influences the qual-
ity of life of the patients who suffer from it, but the de-
termining factors are not fully understood. In fact, the
most severe forms of the disease are associated with a
worse quality of life, but this relationship is not linear
[8,9]. The factors related to this aspect of the disease
need to be identified in order to improve the quality of
life of the patients [7-9]. Several questionnaires have
been developed to assess HRQoL. Some are used for
specific diseases, while others are generic [7].
The EuroQol-5D (EQ-5D) questionnaire is a generic
tool for measuring HRQoL, applicable in healthy indivi-
duals as well as in patients with a specific disease, which
seems to have demonstrated validity and reliability in
asthma [7]. In this, five health dimensions, stratified into
3 levels, as well as visual analogue scale (VAS) are de-
scriptively evaluated [7].d Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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though not specific for asthma, it is considered valid for
cross-sectional population studies of patients with this
disease [2].
Our aim was to evaluate the factors associated with
HRQoL in patients with asthma, from a multidimen-
sional perspective.
Methods
Patients were included, using multi-stage sampling, from
Primary Care clinics from all the Autonomous Commu-
nities in Spain. The first sampling unit was the Family
Doctors, with 182 doctors being selected. They, in turn,
included between 12 and 20 consecutive patients who
were seen at their clinics, and who met with the previ-
ously defined criteria [10]. The patients were contacted
by telephone from the clinic by their own doctor, and
the data was collected by personal interview between
November 2007 and March 2008.
The patients included were those who were over 18
years-old (adult legal age in Spain), with a confirmed
diagnosis of asthma for at least one year according to
GINA criteria [11], who had visited a Health Centre in
the previous 2 years, and signed the informed consent.
Those individuals who, in the investigator’s opinion,
were unable to read or understand the questionnaires,
or had Chronic Obstructive Pulmonary Disease, were
excluded [10].
Data were collected by personal interview, carried out
by the Family Doctors themselves, with no specific train-
ing for this study.
The HRQoL was assessed using the EQ-5D question-
naire, where the patients themselves evaluated their state
of health in severity levels by dimensions (including the
5 dimensions: mobility, personal care, daily activities,
pain/discomfort, anxiety/depression) which were assessed
at three levels (no problems, moderate problems, serious
problems). An assessment was also made on a more
general VAS scale ranging from 0 (worst state of health)
to 100 (better state of health) [12].
Control of the asthma was determined using the
Asthma Control Questionnaire (ACQ) [13]. Those
patients who obtained an ACQ score lower than 0.75
were considered as well controlled, and those with a
score ≥ 0.75 as not well controlled [10,13].
Using a questionnaire specifically designed for the
study, the characteristics of the asthma disease were col-
lected, as well as the adherence to treatment, and the
socio-demographic variables, including: age, gender,
place of residence (rural/urban), and educational levels
(primary school, secondary school, university).
As regards smoking, they were classified into never
smokers (means never having smoked habitually, no
more than an occasional cigarette), ex-smokers (havebeen active smokers, but have not smoked for at least
6 months), or active smokers (smoke habitually every
day).
Obesity was classified based on the body mass index
(BMI), establishing 3 groups, normal weight (less than
25 kg/m2), overweight (between 25 and 30 kg/m2) and
obese (more than 30 kg/m2).
The incidence of stressful events in the 15 days prior
to completing the questionnaire was evaluated based on
self-reporting by the patients, by asking them if they had
suffered a stressful event in the previous 15 days, in gen-
eral, without suggesting specific examples of a stressful
events, with two response options, yes or no.
Treatment adherence was determined based on 3 vari-
ables: 1) level of therapeutic adherence according to the
doctor; 2) frequency of forgetting the medication accord-
ing to the patient; 3) importance of adherence according
to the patient [10]. This last variable was determined by
asking the patients about their level of agreement (from
0= disagree completely, to 10 = agree completely) with
the following sentence “Strict adherence to the medica-
tion prescribed by my doctor should improve my asthma
symptoms”; and was stratified, by research team consen-
sus, into two categories: <8 and ≥8 [10].
The severity of the asthma (intermittent, mild per-
sistent, moderate persistent, severe persistent) was
determined in accordance with the criteria in the
Global Initiative for Asthma guide (GINA) 2006, based
on the condition of the patient before treatment was
started [11].
The presence of allergy sensitization was reported by
the patients themselves. Questions on going to an Emer-
gency unit, to their Family Doctor or any hospital admis-
sions during the year prior to the study were included in
the questionnaire.
The basic treatment was classified into four, mutually
exclusive, categories: 1) patients treated with oral corti-
costeroids in the previous year; 2) those treated with any
combination of long-acting beta-2 agonists and inhaled
corticosteroids, with any other drug but without oral
corticosteroids; 3) treated with inhaled corticosteroids
without continually taking long-acting beta-2 agonists,
although they may take beta-2 agonists on demand; 4)
only beta-2 agonists [10].
Statistical analysis
The mean, median, standard deviation, maximum and
minimum values were calculated for the continuous
variables, and the absolute and relative frequencies for
the categorical variables.
The influence of the different variables included in the
study on the 5 dimensions of the EQ-5D recoded dichot-
omically (without problems versus with problems) and
the probability of obtaining values greater than the mean
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gistic regression analysis. For the logistic regression
model, all variables with a significance value of P < 0.2 in
the univariate analysis were used as predictive variables
in the multivariate analysis. The level of significance in
the multivariate analysis was defined based on the confi-
dence interval with an alpha error less than 0.05. The
software SAS v8.2 was used. The study was approved by
the Hospital Clínico San Carlos de Madrid Clinical Re-
search Ethics Committee.Results
A total of 2,125 patients were finally included, with
57.7% females, and a mean age of 48 years. The response
rate was 95.4%. The main characteristics of the patients
included are summarized in Table 1.
Through the analysis of the different dimensions eval-
uated with the EQ-5D questionnaire, the worst results
corresponded to anxiety/depression, where 32% of asth-
matics were shown to have problems. On the other
hand, asthma seemed to have little effect on personal
care, as only 8% mentioned problems on this aspect
(Table 2).
Advanced age, a lower education level, greater baseline
severity of the asthma, poor control of the asthma, and
the need to be admitted to hospital had a detrimental ef-
fect on at least 4 of the 5 EQ-5D dimensions (Table 2).
Analyzing the quality of life according to the VAS and
with the EQ-5D index, the characteristics with the most
significant influence on analyzing the QoL by dimen-
sions maintained their impact. Other factors also
demonstrated an independent effect, amongst which the
most significant one corresponded to patients who had
some recent stressful events, or who gave little import-
ance to adherence to treatment (Table 3).Discussion
It appears to be a current need to assess HRQoL in
asthma, although it is still not clear which is the most
suitable tool for assessing it [14]. EQ-5D is a generic
HRQoL questionnaire that correlates well with asthma
specific questionnaires. Also, the broader approach of
generic questionnaires can give them a higher potential
to pick up unexpected aspects or collateral effects of the
disease. These two factors make it reasonably valid for
population studies with asthmatic patients [5,15-17].
Furthermore, being a generic questionnaire, it helps in
making the cost comparison with other chronic illnesses
[14]. The response rate obtained in our study was rela-
tively high (95.4%), and probably associated, at least
partly, with the simplicity and rapidity in completing the
EQ-5D questionnaire; which also makes it easier to use
in daily practice [18].Our results appear to confirm the negative effect of
asthma on HRQoL when assessed with the EQ-5D ques-
tionnaire, and this effect appears worse than that
reported in the general Spanish population [19]. Only
the pain/discomfort dimension and the values obtained
on the VAS for the general population are similar to
those of our asthmatic population, but there are signifi-
cant differences in the rest of the dimensions [19].
Increasing age, lower educational level, poorer asthma
control and requiring hospital admissions were signifi-
cant determining factors of a poorer HRQoL in asth-
matic patients in all the dimensions analyzed, as well as
in the general HRQoL analyzed using the VAS.
Although in some studies with few patients [20], or
with a relatively young population [21] no association
was seen between age and HRQoL, the majority of
authors mention a deterioration in HRQoL with increas-
ing age [5,8,22]. Some factors associated with ageing
could explain this result. On the one hand, there are
changes in lung function, such as an increase in air-
way hyper-responsiveness, accelerated decline in forced
expiratory volume in one second, higher prevalence of
irreversible airway obstruction, increased air trapping,
reduction in chest wall compliance, a decrease in static
elastic recoil pressure of the lung, reduction in respira-
tory muscle strength, as well as changes in chest config-
uration which make respiratory movements difficult
[23,24]. There are also changes in the immune system,
immunosenescence, which increases susceptibility to
infections and malignancy rates [25]. Likewise, a deteri-
oration in sight and hearing, in motor abilities, or even
incipient cognitive impairment, can make adherence
to treatment difficult [23]. Finally, comorbidity is more
frequent in advanced age, as such that it may increase
the symptomatology, and even make it difficult to indi-
cate some treatments that may be suitable for asthma,
but contraindicated by some of the respiratory comor-
bidities [23,24].
Lower health literacy has been reported in patients
with a lower education level, as well as, lower mathemat-
ical skills, more delayed diagnosis of asthma, poorer ac-
cess to health care or less adherence to healthy lifestyles,
which could contribute to the worsening of HRQoL
observed in these patients [26-29].
Hospital admissions are a major predictor of a worse
HRQoL in asthma [8]; but a worse HRQoL is also
associated with a higher probability of hospital admis-
sions [30].
Good control of the disease has a significant effect on
a better HRQoL, which is in agreement with other
authors [5,31]. However, to achieve good control of the
disease does not imply obtaining an optimum HRQoL,
as other factors, such as the presence of the disease it-
self, or the need for treatment and medical care,
Table 1 Factors associated with health-related quality of





Male 726/898 (80.8 %)
Age
≥ 60 years 335/638 (52.5%)
40 to 59 years 551/704 (78.3%)
18 to 39 years 723/783 (92.3%)
BMI (Kg/m2)
≥ 30 243/424 (57.3%)
≥ 25 to 30 656/873 (75.1%)







Non active worker 648/1,029 (63.0%)
Active worker 960/1,094 (87.7%)
Living status
Lives alone 145/237 (61.2%)








Severe persistent 28/90 (31.1%)
Moderate persistent 449/706 (63.6%)




Current or former 601/784 (76.7%)
Alcohol intake
≤ 22.5 grams 705/940 (75.0%)
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Stressful event last 15 days
Yes 207/307 (67.4%)
No 1,394/1,810 (77.0%)
Adherence to treatment (physician’s point of view):




Very good 168/224 (75.0%)
How often do you forget your medication?
>10 times every month 51/76 (67.1%)
6-10 times every month 163/223 (73.1%)
1-5 times every month 764/999 (76.5%)
Never 631/827 (76.3)
Adherence is important (score, patient’s point of view):
< 8 388/531 (73.1%)
≥ 8 1,220/1,591 (76.7%)
Asthma treatment
Oral corticosteroids 62/158 (39.2%)
LABA+ IC 1,114/1,476 (75.5%)
Inhaled corticosteroids 180/209 (86.1%)





Asthma control(physician’s point of view):
Very poor 43/83 (51.8%)
Poor 172/322 (53.4%)
Controlled 504/721 (69.9%)
Total control 889/997 (89.2%)
Asthma control (patient’s point of view)
Very poor 11/41 (26.8%)
Poor 97/191 (50.8%)
Controlled 432/666 (64.9%)
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Table 1 Factors associated with health-related quality of
life (n = 2,125) (Continued)














Number of family physician visits
0 97/112 (86.6%)
< 4 675/786 (85.9%)
≥ 4 831/1,221 (68.1%)
Table 2 Factors associated with health-related quality of








Female 883/1,227 (72.0%) 1
Male 726/898 (80.8%) 1.49 (1.13,1.97)
Age
≥ 60 years 335/638 (52.5%) 1
40 to 59 years 551/704 (78.3%) 1.96 (1.41,2.73)
18 to 39 years 723/783 (92.3%) 4.13 (2.71,6.32)
BMI (Kg/m2)
≥ 30 243/424 (57.3%) 1
≥ 25 to 30 656/873 (75.1%) 1.64 (1.20,2.23)
< 25 709/826 (85.8%) 2.14 (1.50,3.04)
Educational level
None 74/170 (43.5%) 1
Primary 613/900 (68.1%) 1.46 (0.97,2.20)
Secondary 600/706 (85.0%) 1.77 (1.10,2.85)
University 319/345 (92.5%) 3.19 (1.73,5.88)
Occupation
Non active worker 648/1,029 (63.0%) 1
Active worker 960/1,094 (87.7%) 1.43 (1.04,1.97)
Living status
Lives alone 145/237 (61.2%) 1
Lives with someone 1,461/1,885 (77.5%) 1.60 (1.10,2.33)
ACQ score
>1.50 437/792 (55.2%) 1
0.75-1.50 464/561 (82.7%) 2.68 (1.96,3.66)
<0.75 708/772 (91.7%) 4.83 (3.37,6.92)
Hospital admissions
Yes 54/179 (30.2%) 1







≥ 60 years 335/638 (52.5%) 1
40 to 59 years 551/704 (78.3%) 2.25 (1.34,3.75)
18 to 39 years 723/783 (92.3%) 4.30 (1.93,9.54)
Educational level
None 74/170 (43.5%) 1
Primary 613/900 (68.1%) 3.08 (1.89,5.03)
Secondary 600/706 (85.0%) 2.71 (1.40,5.24)
University 319/345 (92.5%) 3.21 (1.20,8.54)
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on the HRQoL [31].
Although there is a known relationship between
asthma and psychological factors, the impact of psy-
chological distress on the health of asthmatics and its
determining factors are not well described [32]. Some
authors observed a worse quality of life in asthmatics
with anxiety and/or depression [33-35]. On the other
hand, Heaney et al., observed that the improvement in
asthma control led to a better quality of life, but did
not change the psychiatric symptoms. [36]. Further-
more, there is no single method to assess negative life
events (NLE), understood as events that occur in the
patient’s life that lead to stress, such as financial losses,
work difficulties, death of a close friend or family, or
other family problems [3]. In our case, this information
was provided by the patients themselves. Behavioural
and pathophysiological changes have been reported as
determining factors in these NLE on asthma. For the
former aspect, self-care could be reduced, or inad-
equate use of the medication [32,37], and for the latter,
an increase in airway inflammation has recently been
demonstrated in asthmatic patients after stressful
events [38].
Patients with more severe forms of asthma have a
worse HRQoL, both in our population and in others
[8,39]. However, a recent population study in the USA
did not see a relationship between severity and the
HRQoL [5]. Another study in a Japanese population,
Table 2 Factors associated with health-related quality of
life, according dimensions of EuroQol-5D questionnaire
(n =2,125) (Continued)
Occupation
Non active worker 648/1,029 (63.0%) 1
Active worker 960/1,094 (87.7%) 2.77 (1.52,5.04)
Living status
Lives alone 145/237 (61.2%) 1
Lives with someone 1,461/1,885 (77.5%) 1.70 (1.03,2.80)
Asthma severity
Severe persistent 28/90 (31.1%) 1
Moderate persistent 449/706 (63.6%) 1.81 (0.98,3.34)
Mild persistent 655/774 (84.6%) 3.32 (1.61,6.85)
Intermittent 476/554 (85.9%) 3.21 (1.38,7.46)
Stressful event last 15 days
Yes 207/307 (67.4%) 1
No 1,394/1,810 (77.0%) 1.99 (1.22,3.26)
Asthma treatment
Oral corticosteroids 62/158 (39.2%) 1
LABA+ IC 1,114/1,476 (75.5%) 1.34 (0.77,2.32)
Inhaled corticosteroids 180/209 (86.1%) 4.07 (1.07,15.48)
SABA or LABA 230/255 (90.2%) 1.76 (0.58,5.33)
ACQ score
>1.50 437/792 (55.2%) 1
0.75-1.50 464/561 (82.7%) 2.49 (1.43,4.36)
<0.75 708/772 (91.7%) 2.69 (1.41,5.14)
Hospital admissions
Yes 54/179 (30.2%) 1







≥ 60 years 335/638 (52.5%) 1
40 to 59 years 551/704 (78.3%) 2.27 (1.63,3.16)
18 to 39 years 723/783 (92.3%) 2.67 (1.80,3.95)
BMI (Kg/m2)
≥ 30 243/424 (57.3%) 1
≥ 25 to 30 656/873 (75.1%) 1.27 (0.93,1.73)
< 25 709/826 (85.8%) 1.43 (1.02,2.02)
Educational level
None 74/170 (43.5%) 1
Primary 613/900 (68.1%) 1.51 (0.99,2.31)
Secondary 600/706 (85.0%) 1.86 (1.16,2.99)
University 319/345 (92.5%) 2.62 (1.49,4.60)
Table 2 Factors associated with health-related quality of
life, according dimensions of EuroQol-5D questionnaire
(n =2,125) (Continued)
Living status
Lives alone 145/237 (61.2%) 1
Lives with someone 1,461/1,885 (77.5%) 1.76 (1.23,2.53)
Asthma severity
Severe persistent 28/90 (31.1%) 1
Moderate persistent 449/706 (63.6%) 1.75 (0.95,3.24)
Mild persistent 655/774 (84.6%) 1.97 (1.04,3.74)
Intermittent 476/554 (85.9%) 1.76 (0.90,3.45)
Asthma treatment
Oral corticosteroids 62/158 (39.2%) 1
LABA+ IC 1,114/1,476 (75.5%) 1.41 (0.88,2.23)
Inhaled corticosteroids 180/209 (86.1%) 2.43 (1.27,4.62)
SABA or LABA 230/255 (90.2%) 1.97 (1.05,3.71)
ACQ score
>1.50 437/792 (55.2%) 1
0.75-1.50 464/561 (82.7%) 3.74 (2.79,5.09)
<0.75 708/772 (91.7%) 7.48 (5.29,10.58)
Hospital admissions
Yes 54/179 (30.2%) 1
No 1,555/1,946 (79.9%) 1.75 (1.14,2.68)
Emergency visits
Yes 503/810 (62.1%) 1







Female 883/1,227 (72.0%) 1
Male 726/898 (80.8%) 1.55 (1.17,2.06)
Age
≥ 60 years 335/638 (52.5%) 1
40 to 59 years 551/704 (78.3%) 2.32 (1.68,3.22)
18 to 39 years 723/783 (92.3%) 5.27 (3.52,7.88)
BMI (Kg/m2)
≥ 30 243/424 (57.3%) 1
≥ 25 to 30 656/873 (75.1%) 1.36 (1.00,1.85)
< 25 709/826 (85.8%) 1.75 (1.25,2.47)
Educational level
None 74/170 (43.5%) 1
Primary 613/900 (68.1%) 1.59 (1.02,2.49)
Secondary 600/706 (85.0%) 1.88 (1.14,3.09)
University 319/345 (92.5%) 2.23 (1.25,3.99)
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Table 2 Factors associated with health-related quality of
life, according dimensions of EuroQol-5D questionnaire
(n =2,125) (Continued)
Occupation
Non active worker 648/1029 (63.0%) 1
Active worker 960/1094 (87.7%) 1.43 (1.06,1.93)
Asthma severity
Severe persistent 28/90 (31.1%) 1
Moderate persistent 449/706 (63.6%) 2.24 (1.14,4.41)
Mild persistent 655/774 (84.6%) 3.35 (1.66,6.75)
Intermittent 476/554 (85.9%) 2.65 (1.28,5.48)
Stressful event last 15 days
Yes 207/307 (67.4%) 1
No 1,394/1,810 (77.0%) 2.04 (1.46,2.83)
ACQ score
>1.50 437/792 (55.2%) 1
0.75-1.50 464/561 (82.7%) 1.80 (1.33,2.44)
<0.75 708/772 (91.7%) 2.78 (1.99,3.88)
Hospital admissions
Yes 54/179 (30.2%) 1
No 1,555/1,946 (79.9%) 2.05 (1.30,3.25)
Emergency visits
Yes 503/810 (62.1%) 1








Female 883/1,227 (72.0%) 1
Male 726/898 (80.8%) 1.84 (1.41,2.41)
Age
≥ 60 years 335/638 (52.5%) 1
40 to 59 years 551/704 (78.3%) 1.35 (0.98,1.87)
18 to 39 years 723/783 (92.3%) 2.37 (1.62,3.47)
Educational level
None 74/170 (43.5%) 1
Primary 613/900 (68.1%) 2.04 (1.33,3.12)
Secondary 600/706 (85.0%) 2.18 (1.36,3.49)
University 319/345 (92.5%) 2.55 (1.49,4.37)
Place of residence
Rural 632/859 (73.6%) 1
Urban 977/1265 (77.2%) 1.28 (1.01,1.62)
Asthma severity
Severe persistent 28/90 (31.1%) 1
Moderate persistent 449/706 (63.6%) 1.74 (0.96,3.15)
Mild persistent 655/774 (84.6%) 2.61 (1.40,4.87)
Intermittent 476/554 (85.9%) 2.27 (1.19,4.33)
Table 2 Factors associated with health-related quality of
life, according dimensions of EuroQol-5D questionnaire
(n =2,125) (Continued)
Stressful event last 15 days
Yes 207/307 (67.4%) 1
No 1,394/1,810 (77.0%) 5.57 (4.08,7.59)
ACQ score
>1.50 437/792 (55.2%) 1
0.75-1.50 464/561 (82.7%) 1.36 (1.01,1.83)
<0.75 708/772 (91.7%) 1.66 (1.21,2.28)
Hospital admissions
Yes 54/179 (30.2%) 1
No 1,555/1,946 (79.9%) 2.09 (1.36,3.22)
Emergency visits
Yes 503/810 (62.1%) 1
No 1,106/1,315 (84.1%) 1.32 (1.02,1.72)
*Adjusted Odds Ratio (Adjusted by all the variables in the Table 1).
NS, Crude Odds Ratio non significant; BMI, Body mass index; SABA, Short-
acting beta2 agonists; LABA, Long-acting beta2 agonists; SD, Standard
Deviation; IC, Inhaled corticosteroids.
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ing severity of asthma in males, but not in females,
establishing the possibility of different “coping styles” be-
tween the sexes [40].
Patients who remain in active employment have a bet-
ter QoL, a similar finding to that of Siroux in a multi-
centre European study [8]. Lack of occupational activity
is associated with a lower socio-economic income and
greater psychological distress, which could be determin-
ing factors in the deterioration of the QoL [3,41].
Living in an urban setting is associated with a better
HRQoL. The same relationship was observed in a large
study with Spanish children, suggesting the possibility
that urban areas could have better access to the health
system [42]. Other differences have also been identified
in the management of the disease, with a lower likeli-
hood of scheduled follow up or a greater under-
diagnosis in patients in rural areas [43,44].
The damaging effect of living alone appears to be con-
firmed, given that it is associated to a worse QoL. This is
in agreement with other studies, where to live alone was
a predictive factor of more visits to the Emergency De-
partment, worse mental health or longer delay in the
diagnosis [29,45,46].
In other aspects analyzed, our findings agree with
those mentioned in the literature, showing more exacer-
bations [8,30]; female sex [8,47]; less adherence to treat-
ment [48]; being someone who never smoked [5,49]; and
obesity [8,50] are determining factors of a worse quality
of life.
Our study may have some limitations. Firstly, being a
cross-sectional study causality relationships cannot be
Table 3 Factors associated with health-related quality of life: VAS scale (0 =worst health state, 100=best health state);
(n = 2034)
VAS score
N Mean (SD) Adjusted mean differences (CI 95 %)*
Age
≥ 60 years 609 62.38 (17.46)
40 to 59 years 675 68.93 (16.66) 1.78 (−0.38,3.94)
18 to 39 years 750 76.34 (15.33) 4.99 (2.63,7.37)
Educational level
None 162 58.57 (18.52)
Primary 865 66.12 (17.18) 2.41 (−0.63,5.44)
Secondary 667 73.48 (16.02) 4.96 (1.64,8.28)
University 336 76.87 (14.92) 6.30 (2.69,9.90)
Asthma severity
Severe persistent 87 46.78 (17.21)
Moderate persistent 672 65.45 (16.86) 9.01 (5.07,12.96)
Mild persistent 754 72.97 (15.12) 11.40 (7.28,15.52)
Intermittent 520 74.26 (16.96) 9.49 (5.22,13.76)
Smoking habit
Current or former 753 68.47 (17.02)
Never 1,279 70.43 (17.58) 2.51 (1.13,3.89)
Stressful event last 15 days
Yes 296 61.47 (18.61)
No 1,731 71.10 (16.75) 6.17 (4.31,8.03)
Adherence is important (score, patient’s point of view):
< 8 511 65.25 (17.78)
≥ 8 1,521 71.23 (16.98) 4.02 (2.54,5.50)
ACQ score
>1.50 762 58.94 (16.38)
0.75-1.50 541 72.59 (13.89) 9.48 (7.53,11.44)
<0.75 731 78.79 (14.48) 13.26 (11.22,15.29)
Score of VAS scale, and probability of obtaining values greater than the mean on the VAS. Multivariate analysis.
*Adjusted by all the variables in the Table 1.
N, number of cases; VAS, Visual Analogue Scale; CI, Confidence interval; BMI, Body mass index; SABA, Short-acting beta2 agonists; LABA, Long-acting beta2
agonists; IC, Inhaled corticosteroids.
Gonzalez-Barcala et al. Multidisciplinary Respiratory Medicine 2012, 7:32 Page 8 of 10
http://www.mrmjournal.com/content/7/1/32defined. Secondly, the reference NLE is by self-report, as
such any influence of the personality of the patients can-
not be excluded. Thirdly, the selection of the participat-
ing doctors was not strictly randomized. However, given
the high number of participating doctors and the distri-
bution over the whole country, as well as the collection
of data with validated tools like the EQ-5D question-
naire, the inclusion of a significant number of co-
variables that could have an influence on the quality of
life, and the high number of patients analyzed, these
results should be reasonably valid as representative of
the reality of the QoL of asthmatics in Spain and its de-
termining factors.Conclusions
In our study, we could identify some factors related to
worst quality of life in asthma patients.
The most significant were advanced age, lower educa-
tion level, greater baseline severity of the asthma, pres-
ence of stressful events, poor control of the asthma, and
need to be admitted to hospital.
We believe that the identification of factors related to
poor asthma control, and particularly those that could
be changed by the health care system [10], could lead to
an improvement in the situation of asthmatic patients.
Thus, the prevention and treatment of obesity and
smoking, as well as reinforcing health education, seem
Gonzalez-Barcala et al. Multidisciplinary Respiratory Medicine 2012, 7:32 Page 9 of 10
http://www.mrmjournal.com/content/7/1/32to be basic aspects that could be performed by the
health care system.
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